Cargando…
Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease all over the world. Therapeutic strategies targeting its multidirectional pathways are required. Particularly, fibrosis is closely associated with its prognosis. We previously found that B cell-activating factor (B...
Autores principales: | Kanemitsu-Okada, Kozue, Abe, Masanori, Nakamura, Yoshiko, Miyake, Teruki, Watanabe, Takao, Yoshida, Osamu, Koizumi, Yohei, Hirooka, Masashi, Tokumoto, Yoshio, Matsuura, Bunzo, Koizumi, Mitsuhito, Hiasa, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916461/ https://www.ncbi.nlm.nih.gov/pubmed/36768854 http://dx.doi.org/10.3390/ijms24032509 |
Ejemplares similares
-
Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020) -
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022) -
Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
por: Miyake, Teruki, et al.
Publicado: (2022) -
Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease
por: Hirooka, Masashi, et al.
Publicado: (2017) -
Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation
por: Hirooka, Masashi, et al.
Publicado: (2016)